HSA
TDOC icon

Hussman Strategic Advisors’s Teladoc Health TDOC Stock Holding History

Hussman Strategic Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-210,000
Closed -$1.47M – 334
2025
Q4 		$1.47M Buy
210,000
+63,000
+43% +$493K 0.36% 129
2025
Q3 		$1.14M Buy
+147,000
New +$1.15M 0.25% 181

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hussman Strategic Advisors's TDOC Position: Q1 2026 in Review

Hussman Strategic Advisors sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 210,000 shares — an estimated $1.47M sold.

Hussman Strategic Advisors first reported a position in TDOC in Q3 2025 and held it in 2 quarters. The position peaked at $1.47M in Q4 2025. 325 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Hussman Strategic Advisors reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • Hussman Strategic Advisors sold 210,000 Teladoc Health shares in Q1 2026, an estimated $1.47M.
  • Hussman Strategic Advisors first reported a position in Teladoc Health in Q3 2025 and held it in 2 quarters.
  • Hussman Strategic Advisors's Teladoc Health position peaked at $1.47M in Q4 2025.
  • 325 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.